References

1. Sullivan EJ (1998) Lymphangioleiomyomatosis: a review. Chest 114: 1689- 1703. View
2. Johnson S (1999) Lymphangioleiomyomatosis: clinical features, management and basic mechanisms. Thorax 54: 254-264. View
3. Crausman RS, Lynch DA, Mortenson RL, King TE Jr, Irvin CG, et al. (1996) Quantitative CT predicts the severity of physiologic dysfunction in patiens with lymphangioleiomyomatosis. Chest 109: 131-137. View
4. Johnson SR, Cordier JF, Lazor R, Cottin V, Costabel U, et al. (2010) European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J 35: 14-26. View
5. Matsui K, Takeda K, Yu ZX, Valencia J, Travis WD, et al. (2000) Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study. Am J Respir Crit Care Med 161: 1002-1009. View
6. Benden C, Rea F, Behr J, Corris PA, Reynaud-Gaubert M, et al. (2009) Lung transplantation for lymphangioleiomyomatosis: the European experience. J Heart Lung Transplant 28: 1-7. View
7. Prieto C, Zambrano D, Del Cojo E (2004) Linfangioleiomiomatosis pulmonar: presentación de un caso de evolución fulminante y revisión de la literatura. Rev Esp Anestesiol Reanim 51: 595-599. View